Page last updated: 2024-11-06

3,4-dichlorobenzoic acid and Cystic Fibrosis

3,4-dichlorobenzoic acid has been researched along with Cystic Fibrosis in 1 studies

3,4-dichlorobenzoic acid: structure given in first source
3,4-dichlorobenzoic acid : A chlorobenzoic acid carrying chloro substituents at positions 3 and 4.

Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Acebrón-García-de-Eulate, M1
Mayol-Llinàs, J1
Holland, MTO1
Kim, SY1
Brown, KP1
Marchetti, C1
Hess, J1
Di Pietro, O1
Mendes, V1
Abell, C1
Floto, RA1
Coyne, AG1
Blundell, TL1

Other Studies

1 other study available for 3,4-dichlorobenzoic acid and Cystic Fibrosis

ArticleYear
Discovery of Novel Inhibitors of Uridine Diphosphate-
    Journal of medicinal chemistry, 2022, 02-10, Volume: 65, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Binding Sites; Catalytic Domain; Crystallography, X-Ray;

2022